Project Grant HT94252310285
Award Date 8/1/23
Completion Date 7/31/26
Dollars Obligated $1.5M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
- The Defense Health Agency awarded a $1.1 million project grant to the University of Texas Southwestern Medical Center in Dallas, Texas, to support research under the Military Medical Research and Development program. The three-year award beginning in June 2023 will fund the development of a multifunctional immunotherapy nanoparticle to enable innate immunotherapy for kidney cancer. As the prime awardee, UT Southwestern will leverage its expertise in oncology and immunology to advance this...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $1,062,400 project grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective November 1, 2025, through October 31, 2029. The award supports research to identify NEK5 as a hidden driver in kidney cancer, advancing biomedical innovations relevant to military health priorities and public health objectives. As a leading academic...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $319,800 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective November 1, 2025, through October 31, 2028. The award funds research on novel hypoxia-inducible factor 2 (HIF-2) regulators and therapeutic targets for kidney cancer, conducted at the institution's Dallas, Texas campus. This research initiative...
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $450,174 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025, through August 31, 2030. This award, titled "Building on the Foundation of the Academy of Kidney Cancer Investigators," supports biomedical research initiatives focused on kidney cancer investigation. The Military Medical...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $319,693 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective May 1, 2025 through July 31, 2027. The award supports research focused on dissecting the mechanism of selective HIF-2 regulation of PTHRP and hypercalcemia in clear cell renal carcinoma. This biomedical research project aims to advance understanding of...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $1,049,994 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective June 1, 2026 through May 31, 2029. The award supports research investigating the therapeutic potential of detecting and inhibiting cytosolic ADP-ribosylation in ovarian cancer. This three-year research initiative aligns with the Military Medical...
- The University of Texas Health Science Center at Houston received a $544,892 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025 through July 31, 2028. The award supports research and development of a novel peptide-drug conjugate designed to enable precision-targeted DNA damage in neuroendocrine tumors. This research initiative represents the DHA's investment in transforming healthcare for...
- The University of Texas Southwestern Medical Center was awarded a $1,230,000 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research to cotarget the trinity of DNA damage repair sensing kinases in prostate cancer from September 30, 2021 to September 29, 2024. Through this funding, the Medical Center will investigate medical solutions for prostate cancer by exploring inhibition of the ataxia telangiectasia...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $1,311,922 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025, through August 31, 2028. The project, titled "Next-Generation RCC Mouse Models Reproducing Human Oncogenotypes to Advance Therapeutics," supports advanced biomedical research focused on developing innovative animal models...
- The Defense Health Agency (DHA) awarded a $1.297M Project Grant to The University of Texas Southwestern Medical Center under the Military Medical Research and Development program (CFDA 12.420) for a four-year research initiative beginning September 1, 2025. This award supports research to identify immunomodulatory targets of TAZ/SRF (transcriptional cofactors) in sarcomatoid renal cell carcinoma progression. The research deliverables include hypothesis-driven investigations, biomarker discovery,...